|
시장보고서
상품코드
2018386
수술 시뮬레이션 시장 : 시장 규모, 점유율 alc 동향 분석(진료 분야별, 기술별, 용도별, 지역별), 부문별 예측(2026-2033년)Surgical Simulation Market Size, Share & Trends Analysis Report By Specialty, By Technology (Virtual Patient Simulation, 3D Printing), By End Use (Academic Institutes, Hospitals), By Region, And Segment Forecasts, 2026 - 2033 |
||||||
수술 시뮬레이션 시장 개요
세계의 수술 시뮬레이션 시장 규모는 2025년에 5억 3,073만 달러로 추정되며, 2033년까지 18억 438만 달러에 이르고, 2026-2033년 CAGR 16.57%로 성장할 전망입니다.
시장 성장은 의료 기술의 발전, 최소침습 수술에 대한 수요 증가, 수술 교육 및 환자 안전 향상에 대한 집중적인 노력에 의해 주도되고 있습니다.
안전한 외과 의료는 의료 시스템에서 매우 중요하지만 간과되기 쉬운 요소로, 약 50억 명의 사람들이 그 혜택을 받지 못하고 있습니다. '랜싯 월드 서저리 2030 위원회'에 따르면, 세계 인구의 3분의 1을 차지하는 최빈국에서 이뤄지는 수술은 전 세계 수술의 6%에 불과합니다. 큰 과제 중 하나는 인재 육성입니다. 중저소득 국가(LMICs)에서는 공인된 외과 의사가 심각하게 부족하여 의료 서비스 제공에 큰 장벽이 되고 있습니다. 전 세계적으로 숙련된 외과 의사가 부족하고, 수술이 점점 더 복잡해짐에 따라 실제 상황을 재현한 고급 교육 도구의 필요성이 점점 더 커지고 있습니다.
랜싯 위원회는 2030년까지 LMICs의 외과, 마취, 산부인과 의료 인력을 인구 10만 명당 40명으로 늘릴 것을 권고하고 있습니다. 그러나 고소득 국가에서의 전통적인 수련은 7년 이상 소요될 수 있으며, 레지던트의 최대 30%가 레지던트 수료 후 독립적인 진료를 할 준비가 되어 있지 않다고 보고하고 있습니다. 이러한 수술 교육 격차는 의료진의 준비 태세와 환자 결과를 개선하기 위한 수술 시뮬레이션 솔루션에 대한 수요를 촉진하고 있습니다.
가상현실(VR)과 같은 시장의 기술 발전으로 접근성이 향상되고 하드웨어 비용이 절감되어 도입의 주요 장벽을 극복하고 있습니다. 예를 들어, 2023년 11월 시뮬라레 메디컬은 구순구개열 수술 훈련용으로 설계된 고충실도 수술 시뮬레이터의 확장된 포트폴리오에 '치조골 이식(ABG) 시뮬레이터'를 새롭게 추가한다고 발표했습니다.
마찬가지로, 2022년 6월 Vantari VR이 실시한 조사에 따르면, 의료용 VR 교육 프로그램을 통해 의료 실수가 40% 감소한 것으로 나타났습니다. 또한, Vantari VR과 공동으로 실시한 우롱롱대학의 연구에 따르면, 임상 실습생들의 성과가 32% 향상되었고, 안전 및 위생 프로토콜 준수율이 39% 향상되었다고 보고되었습니다. 이러한 결과는 VR 기술이 수술 교육을 강화하고 환자 치료 결과를 향상시킬 수 있는 큰 잠재력을 입증하고 있습니다.
자주 묻는 질문
목차
제1장 분석 방법과 범위
제2장 주요 요약
제3장 수술 시뮬레이션 시장 : 변동 요인, 동향 및 범위
제4장 수술 시뮬레이션 시장 : 진료 분야별 추산·동향 분석
제5장 수술 시뮬레이션 시장 : 기술별 추산·동향 분석
제6장 수술 시뮬레이션 시장 : 최종 용도별 추산·동향 분석
제7장 수술 시뮬레이션 시장 : 지역별 추산·동향 분석(유형별)
제8장 경쟁 구도
LSH 26.05.11Surgical Simulation Market Summary
The global surgical simulation market size was estimated at USD 530.73 million in 2025 and is projected to reach USD 1,804.38 million by 2033, growing at a CAGR of 16.57% from 2026 to 2033. Market growth is driven by advancements in medical technology, increasing demand for minimally invasive procedures, and a focus on enhancing surgical training and patient safety.
Safe surgical care is a critical yet often overlooked component of health systems, with around 5 billion people lacking access. According to the Lancet Commission on Global Surgery 2030, only 6% of global surgeries are performed in the poorest nations, which account for one-third of the world's population. A major issue is workforce training; low- and middle-income countries (LMICs) face severe shortages of certified surgeons, posing significant barriers to care. The global shortage of skilled surgeons, combined with the increasing complexity of surgeries, has intensified the need for advanced training tools that simulate real-life scenarios.
The Lancet Commission recommends expanding the surgical, anesthetic, and obstetric workforce in LMICs to 40 per 100,000 people by 2030. However, traditional training in high-income countries can take over seven years, with up to 30% of trainees reporting a lack of readiness for independent practice post-residency. This gap in surgical education is driving the demand for surgical simulation solutions to improve workforce readiness and patient outcomes.
Technological advancements in the market, such as Virtual Reality (VR), have improved accessibility and reduced hardware costs, overcoming key adoption barriers. For instance, in November 2023, Simulare Medical announced the launch of its Alveolar Bone Graft (ABG) simulator, a novel addition to its expanding portfolio of high-fidelity surgical simulators designed for cleft surgery training.
Similarly, research by Vantari VR in June 2022 found that their medical VR training programs lowered medical errors by 40%. In addition, a University of Wollongong study conducted with Vantari VR reported a 32% improvement in student clinician performance and a 39% boost in adherence to safety and hygiene protocols. These results underscore VR technology's significant potential to enhance surgical education and improve patient care outcomes.
Global Surgical Simulation Market Report Segmentation
This report forecasts revenue growth and provides, at the regional and country level, an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global surgical simulation market based on specialty, technology, end use, and region:
- Specialty Outlook (Revenue, USD Million, 2021 - 2033)
- Cardiac Surgery
- Gastroenterology
- Neurosurgery
- Orthopedic Surgery
- Reconstructive Surgery
- Oncology Surgery
- Transplant
- Others
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Virtual Patient Simulation
- 3D Printing
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Academic Institutes
- Hospitals
- Military Organizations
- Research Organizations
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Specialty
- 1.1.2. Technology
- 1.1.3. End Use
- 1.1.4. Estimates and forecast timeline.
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Approach 2: Volume Analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Specialty Outlook
- 2.2.2. Technology Outlook
- 2.2.3. End Use Outlook
- 2.3. Competitive Insights
Chapter 3. Surgical Simulation Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Advancements in medical technology
- 3.2.1.2. Growing demand for minimally invasive surgeries
- 3.2.1.3. Rising focus on patient safety and error reduction
- 3.2.1.4. Focus on enhancing surgical training
- 3.2.1.5. Shortage of skilled healthcare professionals
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of simulators
- 3.2.2.2. Limited adoption in developing healthcare systems
- 3.2.2.3. Lack of standardization in simulation-based training
- 3.2.3. Market opportunity analysis
- 3.2.3.1. Expansion of Healthcare Infrastructure and Training Centers
- 3.2.4. Market challenges analysis
- 3.2.1. Market driver analysis
- 3.3. Technology Overview
- 3.3.1.1. Virtual Reality (VR)
- 3.3.1.2. Augmented Reality (AR)
- 3.3.1.3. Virtual Patient Simulation
- 3.3.1.4. Artificial Intelligence (AI)
- 3.4. Surgical Simulation Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic landscape
- 3.4.2.3. Social landscape
- 3.4.2.4. Technological landscape
- 3.4.2.5. Environmental landscape
- 3.4.2.6. Legal landscape
- 3.4.1. Industry Analysis - Porter's
- 3.5. Case Studies & Insights
Chapter 4. Surgical Simulation Market: Specialty Estimates & Trend Analysis
- 4.1. Specialty Market Share, 2025 & 2033
- 4.2. Segment Dashboard
- 4.3. Surgical Simulation Market by Specialty Outlook
- 4.4. Cardiac Surgery
- 4.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
- 4.5. Gastroenterology
- 4.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
- 4.6. Neurosurgery
- 4.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
- 4.7. Orthopedic Surgery
- 4.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
- 4.8. Reconstructive Surgery
- 4.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
- 4.9. Oncology Surgery
- 4.9.1. Market estimates and forecast 2021 - 2033 (USD Million)
- 4.10. Transplant
- 4.10.1. Market estimates and forecast 2021 - 2033 (USD Million)
- 4.11. Others
- 4.11.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 5. Surgical Simulation Market: Technology Estimates & Trend Analysis
- 5.1. Technology Market Share, 2025 & 2033
- 5.2. Segment Dashboard
- 5.3. Surgical Simulation Market by Technology Outlook
- 5.4. Virtual Patient Simulation
- 5.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
- 5.5. 3D Printing
- 5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 6. Surgical Simulation Market: End Use Estimates & Trend Analysis
- 6.1. End Use Market Share, 2025 & 2033
- 6.2. Segment Dashboard
- 6.3. Surgical Simulation Market by End Use Outlook
- 6.4. Academic Institutes
- 6.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
- 6.5. Hospitals
- 6.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
- 6.6. Military Organizations
- 6.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
- 6.7. Research Organizations
- 6.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 7. Surgical Simulation Market: Regional Estimates & Trend Analysis, By Type
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework
- 7.5.1.3. Competitive scenario
- 7.5.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive scenario
- 7.5.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive scenario
- 7.5.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.1. U.S.
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework
- 7.6.1.3. Competitive scenario
- 7.6.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.3. France
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework
- 7.6.3.3. Competitive scenario
- 7.6.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.4. Italy
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework
- 7.6.4.3. Competitive scenario
- 7.6.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.5. Spain
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework
- 7.6.5.3. Competitive scenario
- 7.6.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.6. Denmark
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Regulatory framework
- 7.6.7.3. Competitive scenario
- 7.6.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.8. Norway
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Regulatory framework
- 7.6.8.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.1. UK
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework
- 7.7.1.3. Competitive scenario
- 7.7.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.2. China
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive scenario
- 7.7.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.3. India
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework
- 7.7.3.3. Competitive scenario
- 7.7.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Regulatory framework
- 7.7.5.3. Competitive scenario
- 7.7.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Regulatory framework
- 7.7.6.3. Competitive scenario
- 7.7.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.1. Japan
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Regulatory framework
- 7.8.1.3. Competitive scenario
- 7.8.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.8.2. Argentina
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.8.1. Brazil
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Regulatory framework
- 7.9.1.3. Competitive scenario
- 7.9.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Regulatory framework
- 7.9.2.3. Competitive scenario
- 7.9.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Regulatory framework
- 7.9.3.3. Competitive scenario
- 7.9.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Regulatory framework
- 7.9.4.3. Competitive scenario
- 7.9.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.9.1. South Africa
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Key Company Market Share/Position Analysis, 2025
- 8.4. Company Profiles
- 8.4.1. Materialise
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Stratasys
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Surgical Science
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Mentice
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Gaumard Scientific
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Simulab Corporation
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. VirtaMed AG
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. 3-Dmed Learning Through Simulation
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Laerdal Medical
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. 3D Systems, Inc.
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives
- 8.4.11. Osteo3d
- 8.4.11.1. Company overview
- 8.4.11.2. Financial performance
- 8.4.11.3. Product benchmarking
- 8.4.11.4. Strategic initiatives
- 8.4.12. AXIAL3D
- 8.4.12.1. Company overview
- 8.4.12.2. Financial performance
- 8.4.12.3. Product benchmarking
- 8.4.12.4. Strategic initiatives
- 8.4.13. Formlabs
- 8.4.13.1. Company overview
- 8.4.13.2. Financial performance
- 8.4.13.3. Product benchmarking
- 8.4.13.4. Strategic initiatives
- 8.4.14. Kyoto Kagaku Co., Ltd.
- 8.4.14.1. Company overview
- 8.4.14.2. Financial performance
- 8.4.14.3. Product benchmarking
- 8.4.14.4. Strategic initiatives
- 8.4.15. CAE Inc.
- 8.4.15.1. Company overview
- 8.4.15.2. Financial performance
- 8.4.15.3. Product benchmarking
- 8.4.15.4. Strategic initiatives
- 8.4.1. Materialise
